Home / Research Library / Prevalence and Treatment of Diabetes in China, 201...
🧬 Medicine & Biology OpenAlex

Prevalence and Treatment of Diabetes in China, 2013-2018

📅 December 28, 2021 👤 Limin Wang, Wen Peng, Zhenping Zhao et al. 📖 JAMA 📊 948 citations

🤖 Plain-English Summary

Importance: Recent data on prevalence, awareness, treatment, and risk factors of diabetes in China is necessary for interventional efforts. Conclusions and Relevance: In this survey study, the estimated diabetes prevalence was high and increased from 2013 to 2018.

🔑 Key Findings

  • Objective: To estimate trends in prevalence, awareness, treatment, and risk factors of diabetes in China based on national data.
  • Design, Setting, and Participants: Cross-sectional nationally representative survey data collected in adults aged 18 years or older in mainland China from 170 287 participants in the 2013-2014 years and 173 642 participants in the 2018-2019 years.
  • Exposures: Fasting plasma glucose and hemoglobin A1c levels were measured for all participants.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Dec 28, 2021
Journal JAMA
Authors Limin Wang, Wen Peng, Zhenping Zhao, Mei Zhang, Zumin Shi
DOI 10.1001/jama.2021.22208
Citations 948
Source OpenAlex

More 🧬 Medicine & Biology Research